FP7 - HEALTH - Berenice

Benznidazol and Triazol Research group for Nanomedicine and Innovation on Chagas disease

BERENICE is a Collaborative Project which is funded under the European Community's 7th Framework Programme. The project started on the 1st September 2012 and will last for five years.

BERENICE in brief:

Title: "Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas diseasE".
Call: FP7-HEALTH-2012-INNOVATION-1
Acronym: BERENICE
EC contribution: € 2.998.217
Duration: 60 months
Starting date: 01/09/2012
Funding scheme: Collaborative Project
Contract/Grant agreement number: HEALTH-30593

BERENICE (Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas diseasE) has been created to obtain a more effective, better tolerated and cheaper formulation of a drug with trypanocidal activity to cure Chagas disease.

www.berenice-project.eu

Download Leaflet BERENICE